Compare Lloyds Banking Group Plc American Depositary Shares (LYG) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lloyds Banking Group Plc American Depositary Shares vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Lloyds Banking Group Plc American Depositary Shares trades at $5.4 (market cap $76.34B), while Nuvation Bio Inc. Class A Common Stock trades at $5.03 (market cap $1.74B). The key difference: Lloyds Banking Group Plc American Depositary Shares is far larger — about 43.9× Nuvation Bio Inc. Class A Common Stock's market cap, and Lloyds Banking Group Plc American Depositary Shares pays a 4.05% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Lloyds Banking Group Plc American Depositary Shares for 1 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| LYG | NUVB | |
|---|---|---|
Market Cap | $76.34B | $1.74B |
Volume | 16,671,733 | 9,289,619 |
Sector | Financials | Health |
52-Week High | $6.28 | $9.54 |
52-Week Low | $4.42 | $3.41 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $99.66B | $1.33B |
Dividend Yield | 4.05% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Lloyds Banking Group Plc American Depositary Shares
Lloyds Banking Group provides retail, commercial, and insurance services in the United Kingdom. Its banking brands include Lloyds Bank, Halifax, and Bank of Scotland.
Read more on LYG →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
